Nanotechnology Now - Press Release: "BioForce Nanosciences Wins “Most Successful Commercialization” Award"

Home > Press > BioForce Nanosciences Wins “Most Successful Commercialization” Award

Abstract:
BioForce Nanosciences, Inc., a wholly owned subsidiary of BioForce Nanosciences Holdings, Inc. (OTCBB:BFNH), announced today the receipt of an award on June 5th from the Iowa Small Business Innovation Research / Small Business Technology Transfer (SBIR/STTR) program for the "Most Successful Commercialization Result of an SBIR/STTR Funded Project." Since 2002, BioForce has received three SBIR awards totaling $1.3 million, which funded portions of the development of the Nano eNabler™ molecular printer and the SPT™ print cartridges it uses.

BioForce Nanosciences Wins “Most Successful Commercialization” Award

AMES, IA | Posted on July 27th, 2007

BioForce's Founder and CEO, Dr. Eric Henderson accepted the award and says, "BioForce Nanosciences is grateful for our success with the SBIR/STTR grant program, especially that administered by the National Institutes of Health. The SBIR funding has been a tremendous boost to BioForce's product commercialization success. The success is reflected by the Company's 200 percent employee growth during 2006 and BioForce's highest revenues ever in the first quarter of 2007."

The Nano eNabler system dispenses very small drops of liquid onto surfaces with precision and speed. With this innovative surface patterning tool, BioForce offers scientists a practical solution to problems they encounter when developing ultra miniaturized bioanalytical and biomedical devices. The print cartridges used by the Nano eNabler™ system, or surface patterning tools (SPT™), give the Nano eNabler system its unique qualities at the benefit of scientists in many disciplines. SPT print cartridges can have single or multiple print heads for simultaneous printing of a variety of molecular species or materials.

####

About BioForce Nanosciences, Inc.
BioForce Nanosciences develops and commercializes nanotech tools and solutions for the life sciences. For more information, visit http://www.bioforcenano.com.

This news release contains forward-looking information that may be affected by certain risks and uncertainties, including those risks and uncertainties described in the Company’s most recent filings with the Securities and Exchange Commission. The Company’s actual results could differ materially from such forward-looking statements. We assume no duty to update these statements at any future date.

For more information, please click here

Contacts:
RedChip Companies Inc.
Investor Relations:
Robert Rehse, 1-800-REDCHIP (733-2447) ext 111
or
BioForce Nanosciences, Inc.
Deb Happe, 515-233-8333, Ext. 123
Director of Communications

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark: